- Filed
- Aug 19, 2025 12:00 AM ET
- Period of report
- —
Amendment.
Amends a previously filed report.
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2024 · Aug 18, 2025 | 19.68M sh |
| Shares Diluted | Q1 2024 · Mar 31, 2024 | 3.82M sh |
| Shares Diluted restated | Q1 2024 · Mar 31, 2023 | 11.63K sh |
| Short Term Debt | Q1 2024 · Mar 31, 2024 | $0 |
| Stockholders Equity | Q1 2024 · Mar 31, 2024 | $1.21M |
| Stockholders Equity | Q1 2024 · Dec 31, 2023 | $731.42K |
| Stockholders Equity restated | Q1 2024 · Mar 31, 2023 | −$1.92M |
| Stockholders Equity restated | Q1 2024 · Dec 31, 2022 | −$1.74M |
| Current Liabilities | Q1 2024 · Mar 31, 2024 | $15M |
| Current Liabilities | Q1 2024 · Dec 31, 2023 | $13.86M |
| Total Liabilities | Q1 2024 · Mar 31, 2024 | $15.35M |
| Total Liabilities | Q1 2024 · Dec 31, 2023 | $14.12M |
| Current Assets | Q1 2024 · Mar 31, 2024 | $15.91M |
| Current Assets | Q1 2024 · Dec 31, 2023 | $14.18M |
| Total Assets | Q1 2024 · Mar 31, 2024 | $22.61M |
| Total Assets | Q1 2024 · Dec 31, 2023 | $20.75M |
| Sga Expense restated | Q1 2024 · Mar 31, 2024 | $851.4K |
| Sga Expense restated | Q1 2024 · Mar 31, 2023 | $987.92K |
| Net Income | Q1 2024 · Mar 31, 2024 | −$283.1K |
| Net Income | Q1 2024 · Mar 31, 2023 | −$15.99K |
| Operating Income | Q1 2024 · Mar 31, 2024 | $218.99K |
| Operating Income restated | Q1 2024 · Mar 31, 2023 | $757.55K |
| Gross Profit restated | Q1 2024 · Mar 31, 2024 | $1.37M |
| Gross Profit restated | Q1 2024 · Mar 31, 2023 | $1.75M |
| Cost Of Revenue | Q1 2024 · Mar 31, 2024 | $948.15K |
| Cost Of Revenue restated | Q1 2024 · Mar 31, 2023 | $956.3K |